从 idelalisib 治疗复发性惰性淋巴瘤的 2 期研究中获得长达 6 年随访的患者的结果。
关键词: Idelalisib PI3K inhibitor Waldenström’s macroglobulinemia follicular lymphoma indolent non-Hodgkin lymphoma marginal zone lymphoma
Mesh : Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Humans Lymphoma, Non-Hodgkin / drug therapy Purines / adverse effects Quinazolinones / adverse effects Rituximab / adverse effects
来 源:
DOI:10.1080/10428194.2020.1855344
PDF(Sci-hub)